ICD. The term “
ICD. 9-CM Codes: International Classification of Diseases, 9th Revision, Clinical Modification
ICD. 10-CM Diagnosis Codes: International Classification of Diseases, Tenth Revision, Clinical Modification, a classification system for diseases, procedures, conditions, causes, etc. References to ICD-10- CM Diagnosis Codes include codes set forth in subsequent revisions of the publication.
ICD. 10 code(s) or any other codes, as recommended by the Authority, for Final diagnosis*:
ICD. The Khurja ICD is co-located with a state-of-the-art Rail Terminal and FTWZ. ICD- Khurja is the only private ICD in the country to have exclusive connectivity with 6-lane private rail siding offering regular and prompt rail connectivity through owned xxxxx to all the major gateway ports that service the northern region of India. ICD Khurja is located strategically with multiple road approaches from the major 4/6 lane highways providing a congestion-free movement of cargo and containers. The Group intends to reorganize its corporate structure and integrate / consolidate its operations by housing the following businesses into two different entities / separate verticals:
ICD. 2025 will sign a separate contract with the Professional Congress Organizer (PCO), to which ICD 2025 may delegate responsibility for all logistical and administrative aspects of the ICD 2025.
ICD. O-3 histology and behavior codes were combined into the following testicular cancer histologic categories: seminoma (9061, 9062, 9063, 9064/3), embryonal carcinoma (9070), yolk sac tumor (9071), teratoma (9080, 9082, 9084), mixed germ cell tumor (9081, 9085, 9101, 9102) , choriocarcinoma (9100), unspecified nonseminoma (9065), unspecified testicular cancer (8000, 8010, 8012, 0000), xxx-xxxx cell (8631, 8640, 8650, 8800, 8801, 8900, 8910, 8912). The 17 SEER cancer registries were grouped into the U.S. Census Bureau’s 4 geographical regions: Midwest (Metropolitan Detroit, Iowa), Northeast (Connecticut, New Jersey), South (Metropolitan Atlanta, Rural Georgia Kentucky, Louisiana), and West (San Francisco-Oakland, New Mexico, Seattle (Puget Sound), Utah, San Xxxx-Monterey, Los Angeles, California (excluding San Francisco, Los Angeles, and San Xxxx), and Alaska) (20). Other variables of interest included age (SEER variable: Age at diagnosis), SEER Summary Stage (Summary stage 2000 (1998+); Localized, Regional, Distant), and the laterality of the testicular malignancy (Laterality (1973+)).
ICD. 9 CODE DESCRIPTION NC BH MED CLIN REV. 305.21 CANNABIS USE, CONTINUOUS X 305.22 CANNABIS ABUSE, EPISODIC X 305.23 CANNABIS ABUSE, IN REMISSION X 305.3 HALLUCINOGEN-HALLUCINOSIS X 305.31 HALLUCINOGENIC ABUSE, CONTINUOUS X 305.32 HALLUCINOGENIC ABUSE, EPISODIC X 305.33 HALLUCINOGENIC ABUSE, IN REMISSION X 305.4 SEDATIVE OR HYPNOTIC-INTOXICATION X 305.41 BARBITURATE & SIMIL ACTING SEDATIVE OR HYPN ABUSE, CONT X 305.42 BARBITURATE & SIMIL ACTING SEDATIVE OR HYPN ABUSE, EPISODIC X 305.43 BARBITURATE & SIMIL ACTING SEDATIVE OR HYPN ABUSE, IN REM X 305.5 OPIOID-INTOXICATION X 305.51 OPIOID ABUSE, CONTINUOUS X 305.52 OPIOID ABUSE, EPISODIC X 305.53 OPIOID ABUSE, IN REMISSION X 305.6 COCAINE ABUSE X 305.6 COCAINE-INTOXICATION X 305.61 COCAINE DEPENDENCE-CONTINUOUS X 305.62 COCAINE ABUSE-EPISODIC X 305.63 COCAINE ABUSE, IN REMISSION X 305.7 AMPHETAMINE-INTOXICATION X 305.71 AMPHETAMINE OR REL ACTING SYMPATHOMIM ABUSE, CONTIN X 305.8 ANTIDEPRESSANT TYPE ABUSE, UNSPECIFIED X 305.81 ANTIDEPRESSANT TYPE ABUSE, CONTINUOUS X 305.82 ATNIDEPRESSANT TYPE ABUSE, EPISODIC X 305.83 ANTIDEPRESSANT TYPE ABUSE, IN REMISSION X 305.9 INHALANT-INTOXICATION X 305.91 DRUG ABUSE NEC - CONTIN X 306 PHYSIOLOGICAL MALFUNCTIONS ARISING FROM MENTAL FACTORS X 306 MUSCULOSKELETAL X 306.1 RESPIRATORY X 306.2 CARDIOVASCULAR X 306.3 SKIN X 306.4 GASTROINTESTINAL X 306.5 GENITOURINARY X 306.51 VAGINISMUS X 306.52 PSYCHOGENIC DYSMENORRHEA X 306.53 PSYCHOGENIC DYSURIA X 306.59 OTHER PHYSIOLOGICAL MALFUNCTIONS X 306.6 ENDOCRINE X 306.7 ORGANS OF SPECIAL SENSE X 306.8 OTHER SPECIFIED PSYCHOPHYSIOLOGICAL MALFUNCTIONS X 306.9 UNSPECIFIED PSYCHOPHYSIOLOGICAL MALFUNCTIONS X 307 STAMMERING & STUTTERING X 307 STUTTERING X 307.1 ANOREXIA NERVOSA X 307.1 ANOREXIA NERVOSA X 307.2 TIC D/O NOS X 307.2 TIC DISORDER NOS X 307.21 TRANSIENT TIC DISORDER X 307.22 CHRONIC MOTOR OR VOCAL TIC DISORDER X 307.23 TOURETTE'S SYNDROME X 307.3 STEREOTYPE/HABIT DISORDER X 307.3 STEREOTYPE/HABIT DISORDER X 307.4 SPECIFIC DISORDERS OF SLEEP OF NONORGANIC ORIGIN X 307.4 DYSSOMNIA NOS X 307.41 TRANSIENT DISORDER OF INITIATING OR MAINTAINING SLEEP X 307.42 DYSSOMNIAS-PRIMARY INSOMNIA (NON-ORGANIC) X ICD-9 CODE DESCRIPTION NC BH MED CLIN REV. 307.43 TRANSIENT DISORD OF INITIATING OR MAINTAINING WAKEFULNESS X 307.44 HYPERSOMNIA DISORDER-RELATED TO ANOTHER MENTAL DIS X 307.45 HYPERSOMNIA DISORDER-SLEEP-WAKE SCHEDULE DISORDER X 307.46 PARASOMNIAS-SLEEP TERROR/SLEEPWALKING DISORDER X 307.47 PARASOMNIAS-DREAM ANXIETY DISORDER (NIGHTMARE ...
ICD. 9, ICD-10, DSM, or other diagnosis/surgery code updating service; and
ICD. 11 “The term “ICD-11” shall mean the Eleventh Revision of the International Statistical Classifications of Diseases and Related Health Problems, as may be revised or amended from time to time, or a successor classification. 1.17. Initiation The term “Initiation” or “Initiate” shall mean the date that a human is first dosed with the Products. 1.18. Know-How The term “Know-How” shall mean data, knowledge and information, including materials, samples, chemical manufacturing data, toxicological data, pharmacological data, preclinical data, assays, platforms, formulations, specifications, quality control testing data, that are necessary or reasonably useful for the research, manufacture, development or commercialization of Compounds and Products. 1.19. License Agreement The term "License Agreement" shall mean the license agreement entered into between Roche and Eleven Biotherapeutics, Inc., now Sesen, effective as of June 10, 2016, as amended. 1.20. Lien The term “Lien” shall mean (i) any lien, charge, encumbrance, security interest, right to use, license, including but not limited to, interests arising from options, pledges, mortgages, indentures, security agreements, rights of first refusal or rights of pre-
